|
1
|
GLOBOCAN. 2008, Cancer fact sheet.
http://globocan.iarc.fr/factsheets/cancers.
|
|
2
|
Simonetti RG, Liberati A, Angiolini C and
Pagliaro L: Treatment of hepatocellular carcinoma: a systematic
review of randomized controlled trails. Ann Oncol. 8:117–136. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weiman A, Oldhafer KJ and Pichlmayr R:
Primary liver cancer. Curr Opin Oncol. 7:387–396. 1995. View Article : Google Scholar
|
|
4
|
Gasic GJ, Gasic TB and Stewart CC:
Anti-metastatic effects associated with platelet reduction. Proc
Natl Acad Sci USA. 61:46–52. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gasic GJ, Gasic TB and Murphy S:
Anti-metastatic effect of aspirin. Lancet. 2:932–933. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kolenich JJ, Mansour EG and Flynn A:
Haematological effects of aspirin. Lancet. 2:7141972. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jaffe BM: Prostaglandin and cancer: an
update. Prostaglandins. 6:453–461. 1974. View Article : Google Scholar
|
|
8
|
Bennett A and Del TM: Proceedings:
prostaglandins in human colonic carcinoma. Gut.
16:4091975.PubMed/NCBI
|
|
9
|
Herschman HR: Prostaglandin synthase 2.
Biochim Biophys Acta. 1299:125–140. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vane JR: Inhibition of prostaglandin
synthesis as a mechanism of action for aspirin-like drugs. Nat New
Biol. 231:232–235. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chell S, Kadi A, Williams AC and Paraskeva
C: Mediators of PGE2 synthesis and signalling downstream of COX-2
represent potential targets for the prevention/treatment of cancer.
Biochim Biophys Acta. 1766:104–119. 2006.PubMed/NCBI
|
|
12
|
Wang D and DuBois RN: Prostaglandins and
cancer. Gut. 55:115–122. 2006. View Article : Google Scholar
|
|
13
|
Kashfi K and Rigas B: Non-COX-2 targets
and cancer: expanding the molecular target repertoire of
chemoprevention. Biochem Pharmacol. 70:969–986. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shureiqi I, Xu X and Chen D: Nonsteroidal
anti-inflammatory drugs induce apoptosis in esophageal cancer cells
by restoring 15-lipoxygenase-1 expression. Cancer Res.
61:4879–4884. 2001.PubMed/NCBI
|
|
15
|
Zhang Z and DuBois RN: Par-4, a
proapoptotic gene, is regulated by NSAIDs in human colon carcinoma
cells. Gastroenterol. 118:1012–1017. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Yu J, Park BH, Kinzler KW and
Vogelstein B: Role of BAX in the apoptotic response to anticancer
agents. Science. 290:989–992. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bellosillo B, Pique M and Barragan M:
Aspirin and salicylate induce apoptosis and activation of caspases
in B-cell chronic lymphocytic leukaemia cells. Blood. 92:1406–1414.
1998.PubMed/NCBI
|
|
18
|
Raza H, John A and Benedict S:
Acetylsalicylic acid-induced oxidative stress, cell cycle arrest,
apoptosis and mitochondrial dysfunction in human hepatoma HepG2
cells. Eur J Pharmacol. 668:15–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwenger P, Bellosta P, Vietor I,
Basilico C, Skolnik Y and Vilcek J: Sodium salicylate induces
apoptosis via p38 mitogen activated protein kinase but inhibits
tumour necrosis factor-induced c-Jun N-terminal
kinase/stress-activated protein kinase activation. Proc Natl Acad
Sci USA. 94:2869–2873. 1997. View Article : Google Scholar
|
|
20
|
Zimmermann KC, Waterhouse NJ, Goldstein
JC, Schuler M and Green DR: Aspirin induces apoptosis through
release of cytochrome c from mitochondria. Neoplasia.
2:505–513. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan TA, Morin PJ, Vogelstein B and
Kinzler KW: Mechanisms underlying non-steroidal anti-inflammatory
drug-mediated apoptosis. Proc Natl Acad Sci USA. 95:681–686. 1998.
View Article : Google Scholar
|
|
22
|
Zhou XM, Wong BC and Fan XM: Non-steroidal
anti-inflammatory drugs induce apoptosis in gastric cancer cells
through up-regulation of bax and bak. Carcinogenesis. 22:1393–1397.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mahdi JG, Alkarrawi MA, Mahdi AJ, Bowen ID
and Humam D: Calcium salicylate-mediated apoptosis in human HT01080
fibrosarcoma cells. Cell Prolif. 39:249–260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chinnaiyan AM and Dixit VM: The cell-death
machine. Curr Biol. 6:555–562. 1996. View Article : Google Scholar
|
|
25
|
Kasibhatla S and Tseng B: Why target
apoptosis in cancer treatment? Mol Cancer Ther. 2:573–580.
2003.PubMed/NCBI
|
|
26
|
Makin G: Targeting apoptosis in cancer
chemotherapy. Expert Opin Ther Targets. 6:73–84. 2002. View Article : Google Scholar
|
|
27
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: a link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xiang S, Sun Z, He Q, Yan F, Wang Y and
Zhang J: Aspirin inhibits ErbB2 to induce apoptosis in cervical
cancer cells. Med Oncol. 27:379–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee JH, Park SE, Hossain MA, Kim MY, Kim
MN, Chung HY, Choi JS, Yoo YH and Kim ND:
2,3,6-Tribromo-4,5-dihydroxybenzyl methyl ether induces growth
inhibition and apoptosis in MCF-7 human breast cancer cells. Arch
Pharm Res. 30:1132–1137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SE, Park C, Skim SH, Hossain MA, Kim
MY, Chung HY, Son WS, Kim GY, Choi YH and Kim ND: Korean red
ginseng extract induces apoptosis and decreases telomerase activity
in human leukemia cells. J Ethnopharmacol. 121:304–312. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park SE, Lee SW, Hossain MA, Kim MY, Kim
MN, Ahn EY, Park YC, Suh HS, Kim GY, Choi YH and Kim ND: A
chenodeoxycholic derivative, HS-1200, induces apoptosis and cell
cycle modulation via Egr-1 gene expression control on human
hepatoma cells. Cancer Lett. 270:77–86. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rosse T, Olivier R, Monney L, Rager M,
Conus S and Fellay I: Bcl-2 prolongs cell survival after
Bax-induced release of cytochrome c. Nature. 391:496–499.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zou H, Li X and Wang X: An Apaf-1,
cytochrome c multimeric complex is a functional apoptosome
that activates procaspase-9. J Biol Chem. 274:11549–11556.
1999.
|
|
35
|
Burz C, Berindan-neagoe I, Balacescu O and
Irimie A: Apoptosis in cancer: key molecular signaling pathways and
therapy targets. Acta Oncol. 48:811–821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wolf BB and Green DR: Suicidal tendencies:
apoptotic cell death by caspase family proteinases. J Biol Chem.
274:20049–20052. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stark LA, Reid K, Sansom OJ, Din FV,
Guichard S, Mayer I, Jodrell DI, Clarke AR and Dunlop MG: Aspirin
activates the NF-κB signaling pathway and induces apoptosis in
intestinal neoplasia in two in vivo models of human colorectal
cancer. Carcinogenesis. 28:968–976. 2007.
|
